ISBN-13: 9786206777526 / Angielski / Miękka / 100 str.
HER2-positive breast cancer represents a major challenge in oncology, but also a remarkable therapeutic success story. This book offers a comprehensive and up-to-date exploration of anti-HER2 therapy, from fundamental discoveries in molecular biology to its practical application in patient management.Much more than a simple review of treatments, this book dives to the heart of HER2 biology, deciphering the molecular mechanisms that make it such a crucial therapeutic target. It traces the meteoric evolution of anti-HER2 therapies, from the first monoclonal antibodies to the latest generation of antibody-drug conjugates and tyrosine kinase inhibitors.